ClinicalTrials.gov
public full text
Public Domain
COVID-19 With Convalescent Plasma
To clarify the effects of convalescent plasma therapy on SARS-CoV-2 negative conversion rate during hospital stay and 28-day mortality of severe and life-threatening COVID-19 patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19#913088
- The Effectiveness of ACB-IP 1.0 Convalescent Plasma in COVID-19 Infection#871069
- Convalescent Plasma for the Treatment of COVID-19#888372
- Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions#903862
- Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory Support#888177
Record · ID 908583
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive